BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 8579123)

  • 1. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
    Ueda Y; Imai K; Tsuchiya H; Fujimoto N; Nakanishi I; Katsuda S; Seiki M; Okada Y
    Am J Pathol; 1996 Feb; 148(2):611-22. PubMed ID: 8579123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
    Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
    Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone.
    Mak IW; Seidlitz EP; Cowan RW; Turcotte RE; Popovic S; Wu WC; Singh G; Ghert M
    Hum Pathol; 2010 Sep; 41(9):1320-9. PubMed ID: 20573369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.
    Grignon DJ; Sakr W; Toth M; Ravery V; Angulo J; Shamsa F; Pontes JE; Crissman JC; Fridman R
    Cancer Res; 1996 Apr; 56(7):1654-9. PubMed ID: 8603416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
    Cha HJ; Bae SK; Lee HY; Lee OH; Sato H; Seiki M; Park BC; Kim KW
    Cancer Res; 1996 May; 56(10):2281-4. PubMed ID: 8625299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in giant cell tumor of bone: an immunohistochemical study with clinical correlation.
    Schoedel KE; Greco MA; Stetler-Stevenson WG; Ohori NP; Goswami S; Present D; Steiner GC
    Hum Pathol; 1996 Nov; 27(11):1144-8. PubMed ID: 8912822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption.
    Okada Y; Naka K; Kawamura K; Matsumoto T; Nakanishi I; Fujimoto N; Sato H; Seiki M
    Lab Invest; 1995 Mar; 72(3):311-22. PubMed ID: 7898050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
    Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
    Kawashima A; Okada Y; Nakanishi I; Ueda Y; Iwata K; Roessner A
    Gen Diagn Pathol; 1997 Feb; 142(3-4):129-37. PubMed ID: 9065576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.
    Airola K; Karonen T; Vaalamo M; Lehti K; Lohi J; Kariniemi AL; Keski-Oja J; Saarialho-Kere UK
    Br J Cancer; 1999 May; 80(5-6):733-43. PubMed ID: 10360651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of matrix metalloproteinases 2 and 9, tissue inhibitor of metalloproteinases and apoptosis in tissue remodelling in the sheep placenta.
    Riley SC; Webb CJ; Leask R; McCaig FM; Howe DC
    J Reprod Fertil; 2000 Jan; 118(1):19-27. PubMed ID: 10793622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
    Teesalu T; Masson R; Basset P; Blasi F; Talarico D
    Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone.
    Rao VH; Singh RK; Bridge JA; Neff JR; Schaefer GB; Delimont DC; Dunn CM; Sanger WG; Buehler BA; Sawaya R; Nicolson GL; Rao JS
    Clin Exp Metastasis; 1997 Jul; 15(4):400-9. PubMed ID: 9219728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
    Di Girolamo N; Lloyd A; McCluskey P; Filipic M; Wakefield D
    Am J Pathol; 1997 Feb; 150(2):653-66. PubMed ID: 9033278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.
    Hayashi T; Stetler-Stevenson WG; Fleming MV; Fishback N; Koss MN; Liotta LA; Ferrans VJ; Travis WD
    Am J Pathol; 1996 Oct; 149(4):1241-56. PubMed ID: 8863673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
    Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
    Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.
    Schnaper HW; Grant DS; Stetler-Stevenson WG; Fridman R; D'Orazi G; Murphy AN; Bird RE; Hoythya M; Fuerst TR; French DL
    J Cell Physiol; 1993 Aug; 156(2):235-46. PubMed ID: 8344982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.